Publications
Search our bibliography using the filters on the right-hand side.
Displaying 1 through 50 of 98 publications.
Skip to main content
Loria-Rebolledo L, Watson V, Mohan D, Vass CM, Antunes M, Burns D, Ryan M. Over 30 years of discrete choice experiment studies in health economics: systematic review of current practice and reflections on evolving practice. Poster presented at the ISPOR 2025; May 15, 2025. Montréal, Canada.
Vass C, Pinto CA, Myers K, Imai K, Bussberg C, Bhattacharya R, Calhoun SR, Poulos C. Oncologists' and urologists' preferences for adjuvant therapy in renal cell carcinoma: a discrete-choice experiment. Future Oncol. 2025 Mar;21(7):833-42. doi: 10.1080/14796694.2025.2464485
Calhoun SR, Vass C, Myers K, Imai K, Bussberg C, Bhattacharya R, Pinto CA, Poulos C. Patient preferences for adjuvant therapy in renal cell carcinoma: a discrete-choice experiment. Future Oncol. 2025 Mar;21(7):843-51. doi: 10.1080/14796694.2025.2463276
Smith A, Gore JL, Chisolm S, Squires P, Li H, Dave HK, Vass C, Liu X, Mansfield C. Non-muscle invasive bladder cancer treatment selection in an emerging treatment era: a patient preference study. Poster presented at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium; February 13, 2025. San Francisco, CA. [abstract] J Clin Oncol. 2025 Feb 18; 43(Suppl 5):754. doi: 10.1200/JCO.2025.43.5_suppl.754
Villa K, Vass C, Yarlas A, Ruggles J, Bordone L, Kent C, Mansfield C. Patient preferences for attributes of prophylactic treatment in hereditary angioedema: a discrete-choice experiment. Poster presented at the AAAIO/WAO Joint Conference; February 25, 2025. San Diego, CA. [abstract] J Allergy Clin Immunol. 2025 Feb; 155(2 Suppl):AB228. doi: 10.1016/j.jaci.2024.12.701
Smith A, Gore J, Chisolm S, Squires P, Li H, Franco S, Vass C, Liu X, Mansfield C. Muscle invasive bladder cancer treatment selection in an emerging treatment era: a patient preference study. Poster presented at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium; February 13, 2025. San Francisco, CA. [abstract] J Clin Oncol. 2025; 43(Suppl 5):753.
Benitez A, Andrews JS, Shah D, Mansfield C, Ross E, Rao S, Bussberg C, Galinksy J, Konermann-Bernhardt C, Lu M, Vass C. Caregiver preferences for dravet syndrome and lennox-gastaut syndrome treatments across the USA, UK, and Germany. Poster presented at the 2024 American Epilepsy Society (AES) Annual Meeting; December 7, 2024. Los Angeles, CA.
Gelsey FT, Schapiro D, Kosa K, Vass CM, Perez-Nieves M, Pierce A, Poon JL, DiBenedetti D, Mansfield C. Perspectives and preferences of people with type 2 diabetes for the attributes of weekly insulin. Diabetes Ther. 2024 Nov;15(11):2367-79. doi: 10.1007/s13300-024-01652-0
Doane MJ, Boeri M, Vass C, Bussberg C, Panchmatia HR, Citrome L, Sajatovic M. Preferences for attributes of oral antipsychotic treatments: results from a discrete-choice experiment in respondents with schizophrenia or bipolar I disorder. BMC Psychiatry. 2024 Sep 10;24(1):605. doi: 10.1186/s12888-024-06034-
Vass C, Boeri M, Shields G, Seo J. Making use of technology to improve stated preference studies. Patient. 2024 Sep;17(5):483-91. doi: 10.1007/s40271-024-00693-8
Janssen E, Vass C, Levitan B, Hauber B, Bent R, King-Kallimanis B. Effective patient engagement in patient experience data: practical insights from case studies in hard-to-reach populations. Presented at the Drug Information Association (DIA) 2024 Global Annual Meeting; June 18, 2024. San Diego, CA.
Schapiro D, Perez-Nieves M, Vass CM, Ling Poon J, Gelsey FT, Pierce A, Mansfield C. Preferences of people with type 1 diabetes for features of weekly insulin. Poster presented at the American Diabetes Association's 84th Scientific Sessions; June 21, 2024. Orlando, FL. [abstract] Diabetes. 2024 Jun; 73(Suppl 1):831. doi: 10.2337/db24-831-P
Gelsey F, Perez-Nieves M, Vass CM, Ling Poon J, Schapiro D, Pierce A, Mansfield C. Preferences of people with type 2 diabetes for features of weekly insulin. Poster presented at the American Diabetes Association's 84th Scientific Sessions; June 21, 2024. Orlando, FL. [abstract] Diabetes. 2024 Jun; 73(Suppl 1):832. doi: 10.2337/db24-832-P
Mansfield C, Ho KA, Pierce A, Vass C, Liu X, Boroojerdi B, Kiri S. Patient preferences for myasthenia gravis treatments: a discrete-choice experiment. Poster presented at the American Academy of Neurology (AAN) Annual Meeting 2024; April 2024. Denver, CO. [abstract] Neurology. 2024 Apr 9; 102(17 Supplement 1). doi: 10.1212/WNL.0000000000206306
Wright SJ, Vass CM, Ulph F, Payne K. Understanding the impact of different modes of information provision on preferences for a newborn bloodspot screening program in the United Kingdom. MDM Policy Pract. 2024 Mar 4;9(1). doi: 10.1177/23814683241232935
Muhlbacher AC, de Bekker-Grob EW, Rivero-Arias O, Levitan B, Vass C. How to present a decision object in health preference research: attributes and levels, the decision model, and the descriptive framework. Patient. 2024 Feb 10. doi: 10.1007/s40271-024-00673-y
Boeri M, Covilakam BP, Durno N, Vass C, Heisen M. Preference elicitation in health and healthcare using threshold technique: a systematic review. Poster presented at the SMDM 45th Annual North American Meeting; October 24, 2023. Philadelphia, PA.
Boeri M, Heidenreich S, Cappelleri JC, Vass C, Mt-Isa S, Necdet G, Robert V, Garczarek U, Saint-hilary G, Colopy M, Krucien N, Sepulveda JMG. Sample size decisions for discrete choice experiments in pharmaceutical and health care applications. Presented at the SMDM 45th Annual North American Meeting; October 23, 2023. Philadelphia, PA.
McErlane F, Boeri M, Bussberg C, Cappelleri JC, Germino R, Stockert L, Vass C, Huber AM. Adolescent and caregiver preferences for juvenile idiopathic arthritis treatment: a discrete-choice experiment. Pediatr Rheumatol Online J. 2023 Oct 21;21(1):129. doi: 10.1186/s12969-023-00906-8
Vass C, Penton H, Boeri M. Incorporating patient outcomes, preferences, and perspectives into HTA. Presented at the Virtual PSI Scientific Meeting; October 18, 2023.
Vass C, Seo J, von Butler L, Zhang Y. Innovative uses of technology to advance health preference research. Presented at the ISPOR Webinar; September 20, 2023.
Doane MJ, Boeri M, Vass C, Bussberg C, Panchmatia HR, Gasper S, Citrome L, Sajatovic M. Preferences for characteristics of oral antipsychotic treatments: survey results of patients living with bipolar I disorder. Poster presented at the 2023 ISBD Annual Conference; June 22, 2023. Chicago, IL.
Boeri M, Heidenreich S, Cappelleri JC, Vass C, Mt-Isa S, Necdet G, Robert V, Garczarek U, Saint-hilary G, Colopy M, Krucien N, Sepulveda JMG. Sample size calculations for discrete choice experiments in pharmaceutical and health care applications. Poster presented at the 2023 PSI Annual Conference; June 11, 2023. Hammersmith, United Kingdom.
McMichael A, Poulos C, Vass C, Boeri M. A literature review assessing the most common attributes used in stated-preference studies assessing influenza vaccination: do we know what health care professionals value? Poster presented at the ISPOR 2023 Conference; May 7, 2023. Boston, MA. [abstract] Value Health. 2023 Jun; 26(6 supplement):S329-30. doi: 10.1016/j.jval.2023.03.1876
Doane MJ, Boeri M, Vass C, Bussberg C, Panchmatia HR, Gasper S, Citrome L, Sajatovic M. Preferences for characteristics of oral antipsychotic treatments: survey results of patients living with schizophrenia or bipolar I disorder. Poster presented at the 2023 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting; May 30, 2023. Miami Beach, FL.
Doane MJ, Boeri M, Vass CM, Bussberg CJ, Panchmatia HR, Gasper S, Citrome L, Sajatovic M. Preferences for characteristics of oral antipsychotic treatments: survey results of patients living with schizophrenia. Poster presented at the SIRS 2023 Congress; May 13, 2023. Toronto, Canada.
Bhattacharya R, Vass C, Pinto CA, Myers K, Imai K, Bussberg C, Calhoun SR, Poulos C. Exploring perceptions of the risk of recurrence in renal cell carcinoma: evidence from a survey of practicing physicians. Poster presented at the 2023 American Urological Association Annual Meeting; April 28, 2023. Chicago, IL. [abstract] J Urol. 2023 Apr 1; 209(Supplement 4):e271. doi: 10.1097/JU.0000000000003244.15
Vass C, Pinto CA, Myers K, Imai K, Bussberg C, Bhattacharya R, Calhoun SR, Poulos C. Heterogeneity in physician and patient preferences for the treatment of renal cell carcinoma: evidence from latent class analysis. Poster presented at the 2023 ASCO Genitourinary Cancers Symposium; February 16, 2023. San Franciso, CA. [abstract] J Clin Oncol. 2023 Feb 20; 41(Suppl 6):661. doi: 10.1200/JCO.2023.41.6_suppl.661
Calhoun SR, Vass C, Myers K, Imai K, Bussberg C, Bhattacharya R, Pinto CA, Poulos C. Patient and physician preferences for adjuvant treatment of renal cell carcinoma: a discrete-choice experiment. Poster presented at the 2023 ASCO Genitourinary Cancers Symposium; February 16, 2023. San Franciso, CA. [abstract] J Clin Oncol. 2023 Feb 20; 41(Suppl 6):635. doi: 10.1200/JCO.2023.41.6_suppl.635
Shields GE, Wells A, Wright S, Vass C, Davies LM, Doherty P, Capobianco L. A discrete choice experiment to investigate preferences for psychological intervention in cardiac rehabilitation. BMJ Open. 2022 Nov 7;12(11):e062503. doi: 10.1136/bmjopen-2022-062503
Wright S, Dalal G, Vass C, Georgsson S, Payne K. How do women want to receive information about non-invasive prenatal testing? Evidence from a discrete choice experiment. Prenat Diagn. 2022 Oct;42(11):1377-89. doi: 10.1002/pd.6243
Karim S, Craig BM, Vass C, Groothuis-Oudshoorn CGM. Current practices for accounting for preference heterogeneity in health-related discrete choice experiments: a systematic review. Pharmacoeconomics. 2022 Oct 1;40(10):943-56. doi: 10.1007/s40273-022-01178-y
Vass CM, Boeri M, Poulos C, Turner AJ. Matching and weighting in stated preferences for health care. Journal of choice modelling. 2022 Sep;44. doi: 10.1016/j.jocm.2022.100367
Buchanan J, Hill M, Vass CM, Hammond J, Riedijk S, Klapwijk JE, Harding E, Lou S, Vogel I, Hui L, Ingvoldstad-Malmgren C, Soller MJ, Ormond KE, Choolani M, Zheng Q, Chitty LS, Lewis C. Factors that impact on women's decision-making around prenatal genomic tests: an international discrete choice survey. Prenat Diagn. 2022 Jun;42(7):934-46. doi: 10.1002/pd.6159
Vass CM, Boeri M, Karim S, Marshall D, Craig B, Ho KA, Mott D, Ngorsuraches S, Badawy SM, Mühlbacher A, Gonzalez JM, Heidenreich S. Accounting for preference heterogeneity in discrete-choice experiments: an ISPOR Special Interest Group Report. Value Health. 2022 May;25(5):685-94.
Dorgali MV, Longo A, Vass C, Shields G, Harrison R, Scarpa R, Boeri M. A general public study on preferences and welfare impacts of antimicrobial resistance in the United Kingdom. Pharmacoeconomics. 2022 Jan;40(1):65-76. doi: 10.1007/s40273-021-01076-9
Vass CM, Barton A, Payne K. Towards personalising the use of biologics in rheumatoid arthritis: a discrete choice experiment. Patient. 2022 Jan;15(1):109-19. doi: 10.1007/s40271-021-00533-z
Dalal G, Wright SJ, Vass CM, Davison NJ, Vander Stichele G, Smith CH, Griffiths CEM, Payne K, PSORT consortium. Patient preferences for stratified medicine in psoriasis: a discrete choice experiment. Br J Dermatol. 2021 Nov;185(5):978-87. doi: 10.1111/bjd.20482
Dalal G, Wright S, Vass C, Georgsson S, Payne K. Understanding women's preferences for information when making the decision to have non-invasive prenatal testing in Sweden: a discrete choice experiment. Poster presented at the 2021 SMDM Virtual Annual Meeting; October 20, 2021.
Shields GE, Brown L, Wells A, Capobianco L, Vass C. Utilising patient and public involvement in stated preference research in health: learning from the existing literature and a case study. Patient. 2021 Jul;14(4):399-412. doi: 10.1007/s40271-020-00439-2
Vass CM, Boeri M, Poulos C, Turner AJ. Matching and weighting in health preference research. Presented at the 2021 Virtual 12th Meeting of the International Academy of Health Preference Research; June 2021. [abstract] Patient. 2021 Jun 18; p.1-6. doi: 10.1007/s40271-021-00532-0